Company Filing History:
1 out of 321 
1 out of 5 
1 out of 132 
Years Active: 2020
Title: Innovations of Anne-Claire Boschat: Pioneering Methods for CTP Detection
Introduction
Anne-Claire Boschat, an innovative inventor based in Choisy-le-Roi, France, has made significant contributions in the field of biochemistry. With a focus on methods for detecting and quantifying CTP (Cytidine Triphosphate) and CTP synthase activity, her work aims to enhance the understanding of cellular processes and their implications in medical treatments.
Latest Patents
Anne-Claire Boschat holds a notable patent titled "Methods for detecting or quantifying CTP and CTP synthase activity." This invention details a sophisticated method for detecting or quantifying CTP in a cell sample that contains at least two nucleotide triphosphates. It employs cationic ion pairing chromatography coupled with mass spectrometry. Additionally, the patent outlines a method for quantifying CTP synthase activity and emphasizes its applications in screening potential immunosuppressive or anti-cancer compounds, as well as determining the appropriate dosing for such treatments.
Career Highlights
Throughout her career, Anne-Claire has worked with esteemed organizations such as Assistance Publique-Hôpitaux de Paris and Imagine Institut des Maladies Génétiques Necker Enfants Malades. Her experience in these institutions has not only enriched her expertise but also provided her with a platform to advance her research and inventions.
Collaborations
In her professional journey, Anne-Claire has collaborated with notable individuals including Sylvia Sanquer and Sylvain Latour. These partnerships have contributed to her research endeavors and have fostered a collaborative environment in the pursuit of scientific advancement.
Conclusion
Anne-Claire Boschat exemplifies the innovative spirit of contemporary inventors, using her expertise to develop methods that have the potential to significantly impact the fields of immunology and oncology. Her patent highlights her dedication to advancing medical science and improving therapeutic applications, marking her as a notable figure in the realm of biotech inventions.